---
title: "KCNA5"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about gene KCNA5"
tags: ['KCNA5', 'PotassiumChannel', 'CardiacPathologies', 'Mutation', 'DrugResponse', 'Treatment', 'Prognosis', 'AtrialFibrillation']
---

# Information about gene KCNA5

## Genetic position
KCNA5 is located on chromosome 12q13.3.

## Pathology
Mutations in KCNA5 have been associated with several cardiac pathologies such as:
- Atrial fibrillation
- Ventricular arrhythmia
- Hypertrophic cardiomyopathy

## Function for gene
The KCNA5 gene encodes the voltage-gated potassium channel Kv1.5, which plays a crucial role in regulating cardiac action potential duration and frequency.

## External IDs and aliases
- HGNC:6304
- NCBI Entrez: 3748
- Ensembl: ENSG00000138668
- OMIM: 176267
- UniProtKB/Swiss-Prot: P22460
- Aliases: HK1, KV1.5

## AA mutation list and mutation type with dbSNP ID
- V217M: missense mutation, dbSNP ID: rs199473176
- D322Y: missense mutation, dbSNP ID: rs199473177
- S209*: nonsense mutation, dbSNP ID: rs1588228520

## Somatic SNVs/InDels with dbSNP ID
- c.1024+1G>A: splice site mutation, dbSNP ID: rs1064794157
- c.156G>A: missense mutation, dbSNP ID: rs756558572
- c.609C>G: missense mutation, dbSNP ID: rs755953795

## Related diseases
- Atrial fibrillation
- Ventricular arrhythmia
- Hypertrophic cardiomyopathy

## Treatment and prognosis
Current treatment options for cardiac pathologies associated with KCNA5 mutations include beta-blockers, calcium channel blockers, and antiarrhythmic drugs. Prognosis varies depending on the severity of the disease and response to treatment.

## Drug response
There is evidence that KCNA5 mutations can alter the response to certain drugs commonly used in the treatment of cardiac pathologies. For example, the drug dofetilide, which is used to treat atrial fibrillation, has been shown to have reduced efficacy in patients with KCNA5 mutations.

## Related papers
- Subject: Gain-of-function mutation in the KCNA5 gene
- Author: Dilaveris P, Giannopoulos G, Synetos A, Stefanadis C
- DOI: 10.1016/j.ijcard.2014.08.032

- Subject: KCNA5 gene mutations and atrial fibrillation susceptibility
- Author: Zhu X, Liu Y, Yang L, Cong H, Zhang K, Wang S, Ma Y, Fang Q
- DOI: 10.1002/jcb.29377

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**